Hualan Biological Vaccine Inc. (SHE:301207)
China
· Delayed Price · Currency is CNY 16.52
+0.19 (1.16%)
May 16, 2025, 2:45 PM CST
Hualan Biological Vaccine Revenue
Hualan Biological Vaccine had revenue of 24.28M CNY in the quarter ending March 31, 2025, a decrease of -29.05%. This brings the company's revenue in the last twelve months to 1.12B, down -51.39% year-over-year. In the year 2024, Hualan Biological Vaccine had annual revenue of 1.13B, down -53.21%.
Revenue (ttm)
1.12B
Revenue Growth
-51.39%
P/S Ratio
8.80
Revenue / Employee
1.49M
Employees
748
Market Cap
9.84B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |